Skip to content

Vericel VCEL Free cash flow yield

Free cash flow yield at other companies

Stryker logo
StrykerSYK
3.6%+1.1pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
8.2%+1.8pp
LeMaitre Vascular logo
LeMaitre VascularLMAT
3.2%+1.0pp
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-5.7%-1.8pp
Globus Medical logo
Globus MedicalGMED
5.2%0.0pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
3%-2.1pp

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

Based on trailing twelve months.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's free cash flow yield?
Vericel (VCEL) reported free cash flow yield of 2.9% in Q1 2026.
What is the long-term trend for Vericel's free cash flow yield?
Over 3 years (2021 to 2025), Vericel's free cash flow yield has grown at a 5.8% compound annual growth rate (CAGR), from 1.1% to 1.4%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.